Description
The U.S. market for Over-the-Counter (OTC) Pain Medication presents an in-depth analysis of the performance of various analgesics, including non-steroidal anti-inflammatory drugs (NSAID) and topical products in the US market. The analysis captures the performance of the market players, categories and leading brands in terms of revenue growth and volume growth. It also identifies key issues, drivers, challenges, regulations and trends affecting the marketplace.
The report provides a comprehensive analysis of the pain medication products that are currently in the market, as well as those likely to enter the market in future. The study focuses on the market movements and the factors that will fuel sustainable growth. The markets for these products range from the new and emerging, to the comparatively matured. Apart from the broad classification of external and internal analgesics, OTC pain medication products have been categorized into the following five generic groups for the purposes of this study:
- Aspirin
- Acetaminophen
- Other NSAIDs (Ibuprofen, Ketoprofen & Naproxen)
- Combination formulations
- Topical analgesics (external analgesics)
Historical data are provided for 2000 through 2004. Compounded annual growth rates (CAGR) are provided for the periods 2000-2004, with forecast data from 2005 to 2009.
Table of Contents
Chapter one: Executive Summary
- Report Scope
- Definitions and Products
- Acetaminophen
- NSAIDs
- Topical Medications
- Methodology
- Market Overview
- Market Players
- Internal Analgesic Segment
- Topical Analgesic Segment
- Top Brands
- Internal Analgesic Segment
- Topical Analgesic Segment
- Key Issues and Trends
- Rise of Selective Cox Inhibitors
- Prescription Brand Building for Future OTC Switches
- OTC Push from Healthcare Providers
- Growing Healthcare Costs
- Decade of Pain Control and Research
- Prevalence of Self Medication for Pain
- New Channels
- Outlook
- Ageing Population
- OTC Analgesics as Lifesavers
Chapter Two: Industry Overview and Trends
- Introduction
- Definition of Pain
- Pain—The Fifth Vital Sign
- Types of Pain
- Nervous System and Pain
- Prostaglandin—The Pain Trigger
- Analgesic Products and Classifications
- Aspirin Products
- Overview
- The Origin of Aspirin
- Description of Products
- Acetaminophen Products
- Overview
- Description of Products
- Ibuprofen Products
- Overview
- Description of Products
- Naproxen Products
- Overview
- Description of Products
- Ketoprofen Products
- Overview
- Description of Products
- Combination Formulation
- Overview
- Description of Products
- Topical Medications
- Overview
- Description of Products
- Consumer Issues
- Side Effects and Interactions
- Aspirin
- Acetaminophen
- Other NSAIDs
- Side Effects Across the Population
- Drug Interactions
- Product Innovations Reduce Side Effects
- Some Positive Side Effects of OTC Analgesics
- Regulatory Environment
- The Cost Factor
- Approval Process
- Rx-to-OTC Switch
- Labeling Issues
- The Market
- Market Structure
- Top Five Marketers Hold Sway
- Internal Analgesics Continue to Dominate
- Acetaminophen’s Market Hold Slips External Analgesics Increase Presence
- Market Size and Growth
- Key Market Players
- Overall Market
- Internal Analgesics Segment
- Topical Analgesics Segment
- Market Projections
- Key Growth Factors
- Rx to OTC Switch
- Withdrawal of Vioxx Opens Opportunity for OTC Drugs
- Other Health Benefits of Pain Relievers
- The Growth of Generics / Private Label
- Improved Products and Brand Extensions
- Dual Regulatory Status
- Third Class of Drugs
- Key Issues and Trends
- Building Brands in Prescription Category for Future OTC Switch
- Rise of Select Cox Inhibitors and Triptans
- Growing Healthcare Costs
- OTC-Push from Health Care Providers
- Prevalence of Pain among US Populace
- Ageing Population and Pain
- Wide Prevalence of Self-Medication for Pain
- New Channels
- Lower Drug Costs Through Outsourcing
International OTC Trends
Chapter Three: Competitive Market Analysis
Overview
Aspirin
Acetaminophen
- Market Share
- The Rise of Condition-Specific Treatments
- Instant Pain Relievers Holds the Key
Other NSAIDs
External Analgesics
- Market Share
- Innovation Holds the Key
Combination Formulations
- Arrival of Triptans
- Acceptance of Internal Analgesic Powders
Other OTC Analgesics
- Spill-resistant Formulations
Private Labels
Chapter Four: The Consumer
Note on Simmons Survey Data and Figures
Pain Incidence
Frequency of Occurrence
Impact of Pain
Pain at Workplace
Major Pain Ailments
- Demographic Profiles of People Suffering from Pain
- Arthritis
- Backache
- Chronic Pain
- Migraine Headache
Other Major Pain-related Ailments
- Insomnia/sleep Disorder
- Chronic Bronchitis
- Flu
- Nasal allergies/hay fever
Internal Analgesics
- Forms of Pain Relievers Used
- Generation Y Seeks Easier Forms of Pain Medication
- Middle-Aged and Older People Stick to Traditional Tablets, Powders and Caplets
Frequency of Usage
Types of Headache / Pain Relievers Used
- More People Go for Higher Dosages
- Middle-Aged and Women Likely to Use Extra-Strength Versions
- Younger and Higher Strata Prefer Regular Pain Relievers
- Migraine Pain Relievers
- Nighttime Pain relievers
Purpose of Use
- Users of Pain Relievers for Heart Attack/Stroke Prevention
- Migraine Headache — Young adults and females
- Normal Pain conditions — Age group (35-54)
- Menstrual Pain — Younger females / students
- Arthritis and Sleeplessness — Older Population
- Minor Ailments — Hispanics
Brand Preference
- The Common Thread
- Overuse Among African Americans
- Aspirin’s Health Benefits Attract Elders
- Middle Age Groups Prefer Acetaminophen and Other NSAIDs
- Males Prefer Aspirin for Heart Attack Prevention
- Store Brands: No Cheap Image; It’s the Upper Class Who Prefer It
- External Analgesics
- Forms of External Analgesics
- Brand Preference
- Bengay, the most preferred brand
- Purpose of Use
- Muscle Pain: Hispanics and African Americans High Users of External Analgesics
- Menstrual Pain: Low Education and Income Groups Go for External Pain Relief Methods
- The Weekend Warriors
- Children’s Fever / Pain Relievers
- Forms of Children’s Pain Relievers
- Frequency of Use Lower in Children’s Pain Relievers
- Brand Preference
- Attitudes
- Fact Sheet
- Preference for Store Brands
- Older Consumer Influenced by Advertising
- Careless OTC Analgesics Users
- Older Population Careful of Medicine Intake
- Preference for OTC over Prescription
- OTC Meds Preferred for Backache and Migraine
- Demographics Favoring OTC over Prescription
Chapter Five: Marketing and New Product Trends
Advertising and Promotional Guidelines
- Basic Regulatory Standards
- Substantiation of Claims
- Claims Relating to Heart Benefits of Aspirin
- Comparative Advertising
- The Case of Doans
- Contests and Sweepstakes
Prescription Drug Advertising
- Prescription DTC Advertising Norms Relaxed
Consumer Advertising Expenditure
- McNeil — The Leading Ad Spender
- Aleve Tops Bayer’s Ad Spend
- Wyeth’s Advil Brand line — The Second Largest Ad Spend
- Higher Strength Products Lead Ad Spend
Advertising Positioning
- Pain as a Normal Incidence
- Positioning Beyond Just Pain Relief
- Ads Target the Young & the Active
- Aspirin Drugs Play the Heart Card
- The Fight for All Day Pain Relief -Tylenol and Aleve
- Catching in on Drug Interaction
- Liquid and Powders Cash In on the ‘Quick’ Factor
- Celebrity Advertising — ‘Icy Hot’
- Pain-Specific Positioning — Excedrin, The Headache Medicine
- Comparative Advertising
- Patches Positioned as Stylish
- Vioxx’s Absence Presents an Opportunity
- The “Stop. Think. Tylenol’’ Campaign
Marketer’s Promotional Initiatives
- Coupon Promotions Along with Ads and FSIs
- Other Offers
New Product Introductions
- Acetaminophen — McNeil Dominates With New Products
- Ibuprofen Goes External
- Mint Flavor: The New Rage
- External Analgesics See Dynamic New Product Introductions
- Alternate Medications Have Wider Appeal
- Patches: The Hottest Segment
- Selling Points by Package Tags
Retail Distribution
Retail Structure
Sales Trends
- Drugstores Beat Supermarkets as the Largest Sales Channel
- Drug Stores: The Star Performers
- Purchasing Patterns
Retail Trends
- Impulse Purchase High for OTC Products
- Supermarkets Stress on ‘Whole Health and Displays’
- Mail Order and Internet: The New Media
Chapter SIX: Company Profiles
Competitive Summary
Johnson & Johnson
- Overview
- Makers of Tylenol
- OTC Analgesic Product Line
- Performance
- Focus on Strong Branding and Younger Population
Bayer Group
- Overview
- OTC Analgesic Product Line
- Performance
- Bayer: Expanding Its Reach
Wyeth Inc
- Overview
- OTC Analgesic Product Line
- Performance
- Target: Two Novel Medicines Annually
Bristol-Myers Squibb Company
- Overview
- OTC Analgesic Product Line
- Performance
- Focus on New Products
Chattem Inc
- Overview
- OTC Analgesic Product Line
- Performance
- New Product Introductions Drive Sales
GlaxoSmithKline
- Overview
- OTC Analgesic Product Line
- Performance
- Targeting Pharmacies and Doctors
Pfizer
- Overview
- OTC Analgesic Product Line
- Performance
- Largest Pharmaceutical R&D Organization
- Focus on Pharmaceuticals and Healthcare
Novartis
- Overview
- The Consumer Health Division
- OTC Analgesic Product Line
- Performance
- R&D: The Company’s Lifeblood
Rohto Pharmaceutical Co. Ltd.
- Overview
- OTC Analgesic Product Line
- Performance
- Creating Niche Markets
Perrigo Company
- Overview
- Major Divisions
- OTC Analgesic Product Line
- Cost: The Driving Factor
Appendix A: Company Directory
Appendix B: Advertising Tag Lines for Selected Brands
List of Exhibits
Chapter one: Executive Summary
- Table 1-1: U.S. Retail Sales of Analgesics
Chapter Two: Industry Overview and Trends
- Table 2-1: OTC Analgesic Dosages and Relief Time
- Table 2-2: Frequency of Aspirin Dosage
- Table 2-3: Frequency of Ibuprofen Dosage
- Table 2-4: Major Brands in Topical Analgesics
- Table 2-5: Preferred Daily Dosages for OTC Analgesics
- Table 2-6: Disease State and OTC Aanalgesic to Avoid
- Figure 2-1: OTC Review Process
- Figure 2-2: Share of Prescription and OTC drugs
- Figure 2-3: Performances of OTC Categories
- Figure 2-4: U.S. Market by Marketer Ranking
- Figure 2-5: Market Composition External and Internal Analgesics
- Figure 2-6: Analgesics Market Composition
- Table 2-7: U.S. Retail Sales of Analgesics 2000-2004
- Figure 2-7: Analgesics Sales Trends 2000-2004
- Figure 2-8: U.S. Mass-Market Sales of External Analgesics 1999 – 2004
- Figure 2-9: U.S. Mass-Market Sales of Internal Analgesics, 1999 – 2004
- Table 2-8: Top 10 Marketers’ Overall Analgesics Performance 2003-2004
- Figure 2-10: U.S. Sales Projections of Internal and External Analgesics 2005-2009
- Figure 2-11: Generic Drug Approvals, 1996-2003
- Figure 2-12: U.S. National Health Expenditure, 1993-2003
- Figure 2-13: U.S. Spending for Prescription Drugs by
- Source of Funds 1965, 1985, 2000
- Figure 2-14: U.S. Population above 65 Years of Age, 2000-2050
- Figure 2-15: U.S. Pain Prevalence by Age and Type (Osteoarthritis, Backache, Chronic Pain, Rheumatoid Arthritis)
- Table 2-9: Percent of World Population over 65 Years of Age by Region 2000 to 2030
- Table 2-10: Comparative Status of Active Ingredients in Key Pharmaceutical Markets
Chapter Three: Competitive Market Analysis
- Figure 3-1: U.S. Analgesics Market Share by Active Ingredients
- Figure 3-2: The U.S. Market for Aspirin 1999-2004
- Figure 3-3: U.S. Market Share of Aspirin by Leading Competitor 2004
- Figure 3-4: U.S. Sales and Market Share for Aspirin Products by Competitor 1999-2004
- Table 3-1: Marketers’ Brands Sales and Growth in the United States 2003-2004
- Figure 3-5: U.S Market for OTC Acetaminophen 1999-2004
- Figure 3-6: U.S. Market Share for OTC Acetaminophen by Competitor 2004
- Table 3-2: Marketers’ Brands Sales and Performance for OTC Acetaminophen 2003-2004
- Figure 3-7: U.S. Market Size for Other OTC NSAIDs 1999-2004
- Table 3-3: Marketers’ Brands Sales and Performance for OTC Ibubrofen, Ketoprofen, and Naproxen 2003-2004
- Figure 3-8: U.S. Market Size for OTC External Analgesics
- Figure 3-9: U.S. Market Share for External Analgesics by Leading Competitor 2004
- Table 3-4: Marketers’ Brands Sales and Performance for OTC Topical
- Analgesics Segment 2003-2004
- Figure 3-10: U.S. Market for OTC Combination Analgesic Formulations 1999-2004
- Table 3-5: Marketers’ Brands Sales and Performance for OTC Combination Analgesic Formulations 2003-2004
- Figure 3-11: Market Shares of Combination Analgesic Formulations 2003
- Figure 3-12: U.S. Market for Other OTC Analgesics 1999-2004
- Table 3-6: Marketers’ Brands Sales and Performance for Other OTC Analgesics 2003-2004
- Figure 3-13: Market Size of Private Labels 1999-2004
- Figure 3-14: Market Share Across Each Category for Private Labels 2002-2004
Chapter Four: The Consumer
- Table 4-1: Major Pain Ailments, Number of Sufferers, and Percentage of Total Pain Patient Population in the United States, 2004
- Figure 4-1: Frequency of Chronic Pain (Percentage of Pain Sufferers by Pain Duration) 2003
- Figure 4-2: Pain and Its Effect on Day-to-Day Life
- Figure 4-3: Major Pain Types at the Workplace
- Figure 4-4: Negative Impact of Pain at Workplace
- Table 4-2: Demographic Profiles of Arthritis Sufferers
- Table 4-3: Demographic Profiles of Backache Sufferers
- Table 4-4: Demographic Profiles of Chronic Pain Sufferers
- Table 4-5: Demographic Profiles of Migraine Headache Pain Sufferers
- Table 4-6: Demographic Profiles of Insomnia/Sleep Disorder Sufferers
- Table 4-7: Demographic Profiles of Chronic Bronchitis Sufferers
- Table 4-8: Demographic Profiles of Flu Sufferers
- Table 4-9: Demographic Profiles of Nasal Allergies/Hay Fever Sufferers
- Figure 4-5: Different Forms of Pain Relievers Used
- Table 4-10: Demographic Profile of Users of Different Forms of Pain Relievers
- Figure 4-6: Frequency of usage of headache / pain relievers
- Figure 4-7: Types of Headache / Pain Relievers Used
- Figure 4-8: Age-Wise Preference for Regular and Extra-Strength Pain Relievers
- Table 4-11: Types of Headache / Pain Relievers Used
- Figure 4-9: Purpose for Using Headache / Pain Relievers
- Table 4-12: Demographic Profile of People Using Pain Relievers for Heart Attack Prevention
- Table 4-13: Demographics of People Using Pain Relievers for Backache
- Table 4-14: Demographics of People Using Pain Relievers for Muscle or Body Aches
- Table 4-15: Demographics of people Using Pain Relievers for Arthritis/Sleeplessness
- Table 4-16: Demographics of People Using Pain Relievers for Regular/Migraine Headaches
- Table 4-17: Demographics of People Using Pain Relievers for Cold/Fever/Allergies
- Table 4-18: Demographics of people Using Pain Relievers for Menstrual Pain
- Figure 4-10: Age-Wise Preference for Major Brands of Internal analgesics
- Table 4-19: Age-wise Preference of Brands
- Table 4-20: Preference for Brands Based on Ethnic Origin
- Table 4-21: Preference for Brands Based on Education Level
- Table 4-22: Preference for Brands Based on Occupation
- Table 4-23: Preference for Brands Based on Household Income
- Table 4-24: Preference for Brands Based on Gender/Marital Status
- Table 4-25: Preference for Brands Based on Household Size
- Table 4-26: Preference for Brands Based on Age Group of Children in Household
- Figure 4-11: Forms of Pain Relieving Rubs/Liquids Used
- Table 4-27: Forms of Pain Relieving Rubs/Liquids Used by Demographic Characteristic
- Table 4-28: External Analgesic Brand Preference
- Table 4-29: Age-Wise Brand Preference for Pain Relieving Rubs/Liquids
- Table 4-30: Race / Ethnicity-Wise Brand Preference for Pain Relieving Rubs/Liquids
- Table 4-31: Household Income-Wise Brand Preference for Pain Relieving Rubs/Liquids
- Figure 4-12: Purpose for Using External Analgesics
- Table 4-32: Users of External and Internal Analgesics for Different Pain Conditions
- Table 4-33: Comparison of Users of External and Internal Analgesics by Type of Pain
- Table 4-34: Users of External Analgesics for Sports/Exercise-Related Injuries
- Figure 4-13: Forms of Children’s Pain relievers
- Table 4-35: Types of Children’s Fever / Pain Reliever Used
- Figure 4-14: Frequency of Use – Children’s Pain Relievers
- Table 4-36: Brand Preference for Children’s Pain Relievers
- Table 4-37: Brand Comparison for Children’s Pain Relief
- Figure 4-15: Attitude of a Frequent OTC User
- Figure 4-16: Attitude of Careful User of Drugs
- Table 4-38: Attitudinal Preference for Store Brands
- Table 4-39: Demographic Profile of Consumer Influenced by Advertising
- Table 4-40: Demographic Characteristics of Careless OTC Analgesics Users
- Table 4-41: Demographic Characteristics of Careful Drug Users
- Figure 4-17: Preference for OTC over Prescription
- Table 4-42: Demographic Characteristics Favoring OTC Over Prescription for Pain Ailments
- Table 4-43: Attitudes Prescription vs. OTC
Chapter Five: Marketing and New Product Trends
- Table 5-1: Ad Spend Among Marketers in the OTC Analgesic Market 2003
- Table 5-2: Ad Spends as Percentage of Sales along Brands Line 2003
- Table 5-3: Top Advertisement Spending Brands 2003
- Table 5-4: Leading Brands’ Advertisement Spends and Media Channels 2003
- Table 5-5: Positioning Statements in New Product Advertisements
- Table 5-6: Consumer Promotions of Selected New Product Introductions
- Table 5-7: OTC Analgesic New Product Selling Points by Selected Package Tags
- Table 5-8: Innovative Product Launches in the OTC Analgesic Market
- Table 5-9: Selected New Acetaminophen Introductions
- Table 5-10: Selected New Aspirin Introductions
- Table 5-11: Selected New Ibuprofen Introductions
- Table 5-12: Selected New External First Aid Product Introductions
- Table 5-13: Selected New External Dental Need Introductions
- Table 5-14: Selected New External Pain Relief Introductions
- Table 5-15: Selected New External Skin Care Introductions
- Table 5-16: Selected Other External Pain Reliever Introductions
- Table 5-17: Selected Internal Pain Relief Introductions
- Table 5-18: Selected Internal Stomach Relief Introductions
- Table 5-19: Selected Internal Vitamin Introductions
- Table 5-20: Selected Other Internal Pain Relief Introductions
- Figure 5-1: Retail Channel Share of OTC Drug Sales
- Figure 5-2: Sales Comparison: Supermarket and Drugstores for Internal Analgesics, 2002-2003
- Table 5-21: Internal Analgesic Tablets Purchasing Patterns by Outlet
- Table 5-22: Internal Analgesic Liquids’ Purchasing Patterns by Outlet
- Table 5-23: External Analgesics Purchasing Patterns by Outlet
- Figure 5-3: Why Rx Customers Buy OTC While Filling a Prescription
- Table 5-24: Customer Reasons for Choosing OTC Medication Brands in 2004
- Table 5-25: In-Store Behavior by Shopper Segment
- Table 5-26: Top Factors Influencing the Place of OTC drug Purchase
Chapter SIX: Company Profiles
- Figure 6-1: OTC Analgesic Sales for McNeil, 1999-2004
- Figure 6-2: OTC Analgesic Sales for Bayer, 1999-2004
- Figure 6-3: OTC Analgesic Sales for Wyeth, 1999-2004
- Figure 6-4: OTC Analgesic Sales for Bristol Myers-Squibb, 1999-2004
- Figure 6-5: OTC Analgesic Sales for Chattem, 1999-2004
- Figure 6-6: OTC Analgesic Sales for GSK, 1999-2004
- Figure 6-7: OTC Analgesic Sales for Pfizer, 1999-2004
- Figure 6-8: OTC Analgesic Sales for Novartis, 1999-2004
- Figure 6-9: OTC Analgesic Sales for Mentholatum, 1999-2004